spacer
spacer

PDBsum entry 3qis

Go to PDB code: 
protein Protein-protein interface(s) links
Hydrolase/protein binding PDB id
3qis

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
293 a.a.
13 a.a.
Waters ×123
PDB id:
3qis
Name: Hydrolase/protein binding
Title: Recognition of the f&h motif by the lowe syndrome protein ocrl
Structure: Inositol polyphosphate 5-phosphatase ocrl-1. Chain: a. Fragment: ash-rhogap (unp residues 536-901). Synonym: lowe oculocerebrorenal syndrome protein. Engineered: yes. Protein fam109a. Chain: b. Fragment: f&h motif (unp residues 223-235). Synonym: ses1.
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: inpp5f, ocrl, ocrl1. Expressed in: escherichia coli. Expression_system_taxid: 469008. Synthetic: yes. Organism_taxid: 9606
Resolution:
2.30Å     R-factor:   0.198     R-free:   0.238
Authors: M.Pirruccello,L.E.Swan,E.Folta-Stogniew,P.De Camilli
Key ref: M.Pirruccello et al. (2011). Recognition of the F&H motif by the Lowe syndrome protein OCRL. Nat Struct Biol, 18, 789-795. PubMed id: 21666675
Date:
27-Jan-11     Release date:   15-Jun-11    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
Q01968  (OCRL_HUMAN) -  Inositol polyphosphate 5-phosphatase OCRL from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
901 a.a.
293 a.a.
Protein chain
Pfam   ArchSchema ?
Q8N4B1  (SESQ1_HUMAN) -  Sesquipedalian-1 from Homo sapiens
Seq:
Struc:
249 a.a.
13 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class 2: Chain A: E.C.3.1.3.36  - phosphoinositide 5-phosphatase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

      Pathway:
1-Phosphatidyl-myo-inositol Metabolism
      Reaction: a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate) + H2O = a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate) + phosphate
1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate)
+ H2O
= 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate)
+ phosphate
   Enzyme class 3: Chain A: E.C.3.1.3.56  - inositol-polyphosphate 5-phosphatase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

      Pathway:
      Reaction:
1. 1D-myo-inositol 1,4,5-trisphosphate + H2O = 1D-myo-inositol 1,4- bisphosphate + phosphate
2. 1D-myo-inositol 1,3,4,5-tetrakisphosphate + H2O = 1D-myo-inositol 1,3,4-trisphosphate + phosphate
1D-myo-inositol 1,4,5-trisphosphate
+ H2O
= 1D-myo-inositol 1,4- bisphosphate
+ phosphate
1D-myo-inositol 1,3,4,5-tetrakisphosphate
+ H2O
= 1D-myo-inositol 1,3,4-trisphosphate
+ phosphate
   Enzyme class 4: Chain A: E.C.3.1.3.86  - phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate) + H2O = a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4- bisphosphate) + phosphate
1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate)
+ H2O
= 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4- bisphosphate)
+ phosphate
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
Nat Struct Biol 18:789-795 (2011)
PubMed id: 21666675  
 
 
Recognition of the F&H motif by the Lowe syndrome protein OCRL.
M.Pirruccello, L.E.Swan, E.Folta-Stogniew, P.De Camilli.
 
  ABSTRACT  
 
Lowe syndrome and type 2 Dent disease are caused by defects in the inositol 5-phosphatase OCRL. Most missense mutations in the OCRL ASH-RhoGAP domain that are found in affected individuals abolish interactions with the endocytic adaptors APPL1 and Ses (both Ses1 and Ses2), which bind OCRL through a short phenylalanine and histidine (F&H) motif. Using X-ray crystallography, we have identified the F&H motif binding site on the RhoGAP domain of OCRL. Missense mutations associated with disease affected F&H binding indirectly by destabilizing the RhoGAP fold. By contrast, a disease-associated mutation that does not perturb F&H binding and ASH-RhoGAP stability disrupted the interaction of OCRL with Rab5. The F&H binding site of OCRL is conserved even in species that do not have an identified homolog for APPL or Ses. Our study predicts the existence of other OCRL binding partners and shows that the perturbation of OCRL interactions has a crucial role in disease.
 

 

spacer

spacer